Elsevier

The Lancet

Volume 346, Issue 8986, 18 November 1995, Pages 1339-1345
The Lancet

Variation in protection by BCG: implications of and for heterologous immunity

https://doi.org/10.1016/S0140-6736(95)92348-9Get rights and content

Abstract

Besides being the world's most widely used vaccine, and being directed against the world's leading cause of infectious disease mortality, BCG is the most controversial vaccine in current use.1,2 Estimates of protection imparted by BCG against pulmonary tuberculosis vary from nil to 80%. This variability has been attributed to strain variation in BCG preparations, to genetic or nutritional differences between populations, and to environmental influences such as sunlight exposure, poor cold-chain maintenance, or exposure to environmental mycobacterial infections. Evidence accumulated to date indicates that regional differences in environmental mycobacteria are responsible for much of the variation observed between populations in the efficacy of BCG against pulmonary tuberculosis. This paper reviews the evidence, and notes its broader implications for the epidemiology and control of mycobacterial diseases as well as for other infections and vaccines.

References (74)

  • SA. Berggren

    Field experiment with BCG vaccine in Malawi

    Br Vet J

    (1981)
  • V. Romanus

    Chilhood tuberculosis in Sweden

    Tubercle

    (1983)
  • Rg Ferguson et al.

    BCG vaccination of Indian infants in Saskatchewan

    Tubercle

    (1949)
  • VH. Springett

    BCG vacination in Birmingham: an assessment of its contribution to tuberculosis control in 1956-67

    Tubercule

    (1969)
  • Bw Jin et al.

    A contact study to evaluate the BCG vaccination in Seoul

    Tubercle

    (1989)
  • K. Murtagh

    Efficacy of BCG

    Lancet

    (1980)
  • O. Tidjani et al.

    The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community

    Tubercle

    (1986)
  • P. Blin et al.

    Evaluation of the protective effect of BCG vaccination by a case-control study in Yaoundé, Cameroon

    Tubercle

    (1986)
  • Br Bloom et al.

    The BCG experience: implications for future vaccines against tuberculosis

  • Ce Palmer et al.

    Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis

    Am Rev Respir Dis

    (1966)
  • Me Wilson et al.

    Geographic latitude and the efficacy of bacillus Calmette-Guérin vaccine

    Clin Infect Dis

    (1995)
  • PD. Hart

    Efficacy and applicability of mass BCG vaccination in tuberculosis control

    BMJ

    (1967)
  • GW. Comstock

    Identification of an effective vaccine against tuberculosis

    Am Rev Respir Dis

    (1988)
  • I. Sutherland et al.

    Effectiveness of BCG vaccination in England and Wales in 1983

    Tubercle

    (1987)
  • PD'A Hart et al.

    BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life: final report to the Medical Research Council

    BMJ

    (1977)
  • Tuberculosis Prevention Trial Madras. Trial of BCG vaccines in South India for tuberculosis prevention

    Indian J Med Res

    (1980)
  • Ga Colditz et al.

    Efficacy of BCG vaccine in the prevention of tuberculosis

    JAMA

    (1994)
  • Lb Edwards et al.

    Contributions of northern populations to the understanding of tuberculin sensitivity

    Arch Environ Health

    (1968)
  • Lb Edwards et al.

    An atlas of sensitivity to tuberculin, PPB-B, and histoplasmin in the United States

    Am Rev Respir Dis

    (1969)
  • Jo Falkinham et al.

    Epidemiology of infection by nontuberculous mycobcteria. I. Geographic distribution in the Eastern United States

    Am Rev Respir Dis

    (1980)
  • Gw Comstock et al.

    Evaluation of BCG vaccination among Puerto Rican children

    AJPH

    (1974)
  • Pa Orege et al.

    Case control study of BCG vaccination as a risk factor for leprosy and tuberculosis in Western Kenya

    Int J Lepr

    (1994)
  • Ml Edwards et al.

    Infection with Mycobacterium avium-intracellulare and the protective effects of bacille Calmette-Guerin

    J Infect Dis

    (1982)
  • Im Orme et al.

    Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria

    Infect Immun

    (1984)
  • Lb Edwards et al.

    Identification of tuberculous infected: dual tests and density of reaction

    Am Rev Respir Dis

    (1973)
  • JD. Aronson

    Protective vaccination against tuberculosis with special reference to BCG vaccination

    Am Rev Tuberc

    (1948)
  • Cited by (1164)

    View all citing articles on Scopus
    View full text